Learning from combination HIV prevention programmes to face COVID-19 emerging pandemic

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorPALACIOS, Ricardo
dc.contributor.authorMATHIAS, Augusto
dc.date.accessioned2020-10-15T14:39:08Z
dc.date.available2020-10-15T14:39:08Z
dc.date.issued2020
dc.description.abstractBefore a vaccine against SARS-CoV-2 became available, several measures to control COVID-19 pandemic are necessary. Analogously, in the absence of an available vaccine, Combination HIV Prevention Programmes have consolidated a large experience of biomedical, behavioral and structural interventions suitable for several epidemiological settings. Adaptation of such experiences can organize mid-term and long-term responses to face COVID-19.eng
dc.description.abstractAntes de que una vacuna contra el SARS-CoV-2 esté disponible, son necesarias varias medidas para controlar la pandemia de COVID-19. Análogamente, en ausencia de una vacuna disponible, los Programas Combinados de Prevención del VIH han consolidado una gran experiencia de intervenciones biomédicas, conductuales y estructurales adecuadas para varios entornos epidemiológicos. La adaptación de tales experiencias puede organizar respuestas a medio y largo plazo para enfrentar COVID-19.
dc.description.indexMEDLINEeng
dc.identifier.citationCOLOMBIA MEDICA, v.51, n.2, article ID e-4276, 13p, 2020
dc.identifier.doi10.25100/cm.v51i2.4276
dc.identifier.issn1657-9534
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/37938
dc.language.isoeng
dc.publisherCORPORACION EDITORA MEDICA VALLEeng
dc.relation.ispartofColombia Medica
dc.rightsopenAccesseng
dc.rights.holderCopyright CORPORACION EDITORA MEDICA VALLEeng
dc.subjectCOVID-19eng
dc.subjectCoronaviruseng
dc.subjectAcquired Immunodeficiency Syndromeeng
dc.subjectPandemicseng
dc.subjectsevere acute respiratory syndrome coronavirus 2eng
dc.subjectCoronavirus Infectionseng
dc.subjectSevere Acute Respiratory Syndromeeng
dc.subjectImmunizationeng
dc.subjectVaccinationeng
dc.subjectVaccineseng
dc.subjectUnited Nationseng
dc.subjectGovernmenteng
dc.subjectSíndrome de inmunodeficiencia adquirida
dc.subjectPandemias
dc.subjectsíndrome respiratorio agudo severo
dc.subjectInfecciones por coronavirus
dc.subjectSíndrome respiratorio agudo severo
dc.subjectInmunización
dc.subjectVacunación
dc.subjectVacunas
dc.subjectNaciones Unidas
dc.subjectGobierno
dc.subject.otheranal intercourseeng
dc.subject.othercoronaviruseng
dc.subject.otherantibodieseng
dc.subject.otherinfectioneng
dc.subject.othermeneng
dc.subject.othersexeng
dc.subject.wosMedicine, General & Internaleng
dc.titleLearning from combination HIV prevention programmes to face COVID-19 emerging pandemiceng
dc.title.alternativeAprender de los programas combinados de prevención del VIH para enfrentar la pandemia emergente COVID-19
dc.typearticleeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalPALACIOS, Ricardo:Inst Butantan, Clin Trials & Pharmacovigilance Ctr, Sao Paulo, Brazil
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcAUGUSTO MATHIAS
hcfmusp.description.articlenumbere-4276
hcfmusp.description.issue2
hcfmusp.description.volume51
hcfmusp.origemWOS
hcfmusp.origem.scieloSCIELO:S1657-95342020000200003
hcfmusp.origem.scopus2-s2.0-85092509769
hcfmusp.origem.wosWOS:000567329900005
hcfmusp.publisher.cityCALIeng
hcfmusp.publisher.countryCOLOMBIAeng
hcfmusp.relation.referenceAhmed F, 2020, LANCET PUBLIC HEALTH, V5, pE240, DOI 10.1016/S2468-2667(20)30085-2eng
hcfmusp.relation.referenceAnderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5eng
hcfmusp.relation.reference[Anonymous], 2018, JAIDS-J ACQ IMM DEF, V79, P38, DOI [10.1097/QAI.0000000000001726, DOI 10.1097/QAI.0000000000001726]eng
hcfmusp.relation.reference[Anonymous], 2014, UNP H 90 90 90 AMB Teng
hcfmusp.relation.referenceAyres José Ricardo Carvalho Mesquita, 2002, Interface (Botucatu), V6, P11, DOI 10.1590/S1414-32832002000200002eng
hcfmusp.relation.referenceBasthi A, 2016, MYTH VS REALITY EVALeng
hcfmusp.relation.referenceBeanland RL, 2015, CLIN INFECT DIS, V60, pS191, DOI 10.1093/cid/civ070eng
hcfmusp.relation.referenceBryant J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13140eng
hcfmusp.relation.referenceCALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019eng
hcfmusp.relation.referenceCao WCC, 2007, NEW ENGL J MED, V357, P1162, DOI 10.1056/NEJMc070348eng
hcfmusp.relation.referenceCarlos JA, 2010, AIDS EDUC PREV, V22, P430, DOI 10.1521/aeap.2010.22.5.430eng
hcfmusp.relation.referenceCenters for Disease Control and Prevention, 2020, REC REG US CLOTH FACeng
hcfmusp.relation.referenceCenters for Disease Control and Prevention, 2020, INT REC US HOUS SUSPeng
hcfmusp.relation.referenceCheng H, 2020, J MED VIROL, V92, P726, DOI 10.1002/jmv.25785eng
hcfmusp.relation.referenceChoko AT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208191eng
hcfmusp.relation.referenceChow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2eng
hcfmusp.relation.referenceCohen J, 2020, CORONAVIRUS RES COMM, DOI 10.1126/SCIENCE.ABB7733eng
hcfmusp.relation.referenceCohen MS, 2011, NEW ENGL J MED, V365, P493, DOI 10.1056/NEJMoa1105243eng
hcfmusp.relation.referencedi Mauro Beatrice Weder, 2020, MITIGATING COVID ECeng
hcfmusp.relation.referenceDieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828eng
hcfmusp.relation.referenceDonovan B, 2000, SEX TRANSM INFECT, V76, P88, DOI 10.1136/sti.76.2.88eng
hcfmusp.relation.referenceDudley JP, 2020, CLIN INFECT DIS, DOI [10.1101/2020.03.24.20042598, DOI 10.1101/2020.03.24.20042598]eng
hcfmusp.relation.referenceEichenberger R, 2020, CENT RES EC MANAG AReng
hcfmusp.relation.referenceEisinger RW, 2019, JAMA-J AM MED ASSOC, V321, P451, DOI 10.1001/jama.2018.21167eng
hcfmusp.relation.referenceFlowers P, 2001, HEALTH-LONDON, V5, P50, DOI 10.1177/136345930100500103eng
hcfmusp.relation.referenceFonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145eng
hcfmusp.relation.referenceFord N, 2015, CLIN INFECT DIS, V60, pS182, DOI 10.1093/cid/civ093eng
hcfmusp.relation.referenceGardner W, 2020, J AGING SOC POLICY, V32, P310, DOI 10.1080/08959420.2020.1750543eng
hcfmusp.relation.referenceGorbach PM, 2009, SEX TRANSM DIS, V36, P193, DOI 10.1097/OLQ.0b013e3181901ccfeng
hcfmusp.relation.referenceGourinchas P.-O., 2020, MITIGATING COVID EC, P31eng
hcfmusp.relation.referenceGrant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205eng
hcfmusp.relation.referenceGray RH, 2008, LANCET, V371, P2064, DOI 10.1016/S0140-6736(08)60896-Xeng
hcfmusp.relation.referenceHarcourt C, 2010, AUST NZ J PUBL HEAL, V34, P482, DOI 10.1111/j.1753-6405.2010.00594.xeng
hcfmusp.relation.referenceHayes R, 2010, AIDS, V24, pS15, DOI 10.1097/01.aids.0000390704.35642.47eng
hcfmusp.relation.referenceHouser KV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006565eng
hcfmusp.relation.referenceKaplan JE, 2015, CLIN INFECT DIS, V60, pS196, DOI 10.1093/cid/civ087eng
hcfmusp.relation.referenceKhamsi R, 2020, NATUREeng
hcfmusp.relation.referenceKimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1eng
hcfmusp.relation.referenceLaar A, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0129-zeng
hcfmusp.relation.referenceLi RY, 2020, SCIENCE, V368, P489, DOI 10.1126/science.abb3221eng
hcfmusp.relation.referenceLloyd-Sherlock P, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1052eng
hcfmusp.relation.referenceLohiniva AL, 2020, EUROSURVEILLANCE, V25, P17, DOI 10.2807/1560-7917.ES.2020.25.13.2000317eng
hcfmusp.relation.referenceMadjid M, 2020, JAMA CARDIOL, DOI [10.1001/jamacardio.2020, DOI 10.1001/JAMACARDIO.2020]eng
hcfmusp.relation.referenceMaier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557eng
hcfmusp.relation.referenceMandavilli A, 2003, NAT MED, V9, P487, DOI 10.1038/nm0503-487eng
hcfmusp.relation.referenceNelson KM, 2019, J ADOLESCENT HEALTH, V64, P36, DOI 10.1016/j.jadohealth.2018.07.015eng
hcfmusp.relation.referenceNilo F., 2015, B ABTA, V60, P8eng
hcfmusp.relation.referencePAHOeng
hcfmusp.relation.referenceWHOeng
hcfmusp.relation.referenceUNAIDS, 2017, HIV PREV SPOTL AN PE, P88eng
hcfmusp.relation.referenceParsons JT, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000167348.15750.9aeng
hcfmusp.relation.referencePayne DC, 2016, EMERG INFECT DIS, V22, P1824, DOI 10.3201/eid2210.160706eng
hcfmusp.relation.referencePerrusi A, 2012, REV CIENCIAS SOCIAIS, V2, P179eng
hcfmusp.relation.referencePettifor A, 2016, LANCET GLOB HEALTH, V4, pE978, DOI [10.1016/s2214-109x(16)30253-4, 10.1016/S2214-109X(16)30253-4]eng
hcfmusp.relation.referencePrem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6eng
hcfmusp.relation.referencePueyo T, 2020, CORONAVIRUS HAMMER Deng
hcfmusp.relation.referenceSanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282eng
hcfmusp.relation.referenceLe TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5eng
hcfmusp.relation.referenceThienkrua W, 2016, J HOMOSEXUAL, V63, P507, DOI 10.1080/00918369.2015.1088319eng
hcfmusp.relation.referenceUNAIDS, 2010, COMB HIV PREV TAIL Ceng
hcfmusp.relation.referenceUNAIDS, 2010, COMB ION HIV PREV TAeng
hcfmusp.relation.referencevan Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI 10.1056/NEJMc2004973eng
hcfmusp.relation.referenceVekemans J, 2020, LANCET HIV, V7, pE141, DOI 10.1016/S2352-3018(19)30294-2eng
hcfmusp.relation.referenceVermund SH, 2017, JAIDS-J ACQ IMM DEF, V74, pS1, DOI 10.1097/QAI.0000000000001211eng
hcfmusp.relation.referenceVermund SH, 2014, JAIDS-J ACQ IMM DEF, V66, pS237, DOI 10.1097/QAI.0000000000000244eng
hcfmusp.relation.referenceWilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020eng
hcfmusp.relation.referenceWolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239eng
hcfmusp.relation.referenceWorld Health Organization, 2014, CONS GUID HIV PREV D, P184eng
hcfmusp.relation.referenceYork Ashley, 2019, Nat Rev Microbiol, V17, P399, DOI 10.1038/s41579-019-0215-4eng
hcfmusp.relation.referenceZhu Yuner, 2020, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2020.68eng
hcfmusp.scopus.lastupdate2024-06-09
relation.isAuthorOfPublicatione46380c4-dcdc-43f5-af3c-2d6686888602
relation.isAuthorOfPublication.latestForDiscoverye46380c4-dcdc-43f5-af3c-2d6686888602
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_PALACIOS_Learning_from_combination_HIV_prevention_programmes_to_face_2020.PDF
Tamanho:
859.26 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - LIM/38
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/05